Jay Venkatesan - 22 May 2026 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Director
Issuer ticker: SER
Reported as of: 22 May 2026
Net transaction value: +$1,048
SEC form: 4
Accepted by SEC: 22 Jun 2026, 19:15:02 UTC
Prior SEC filing: 21 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Steven Ledger, Attorney in Fact

Key filing fact

Jay Venkatesan filed Form 4 for Serina Therapeutics, Inc. (SER) on 22 Jun 2026.

Key facts

This page summarizes Jay Venkatesan's Form 4 filing for Serina Therapeutics, Inc. (SER).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 19:15.

Change

Previous filing in this sequence was filed on 21 Apr 2026.
Current net transaction value: +$1,048.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001413350 Primary reporting owner

Venkatesan Jay

Relationship: Director
Address: 601 GENOME WAY, SUITE 2001, HUNTSVILLE
Signature: /s/ Steven Ledger, Attorney in Fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SER transaction

Common Stock

Purchase

Transaction value: $1,048
Shares: +589
Change %
Price: $1.78
Shares after: 589
Date: 22 May 2026
Ownership: Direct
Footnotes: F1

SER transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +224,152
Change %: +2968%
Price: $2.25^*
Shares after: 231,705
Date: 17 Jun 2026
Ownership: The Jay Venkatesan Legacy Trust
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SER transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +15,250
Change %
Price: $0.000000^*
Shares after: 15,250
Date: 17 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,250
Exercise price: $1.98
Footnotes: F3

SER transaction Derivative

Series A Convertible Preferred Stock

Conversion of derivative security

Transaction value
Shares: -96,525
Change %: -100%
Price: $2.25^*
Shares after: 0
Date: 17 Jun 2026
Ownership: The Jay Venkatesan Legacy Trust
Underlying class: Common Stock, $0.0001 par value
Underlying amount: 222,222
Exercise price: $5.18
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The share ownership amount has been adjusted to correct an administrative error in a prior Form 4 filed by the Reporting Person, which inadvertently reported 7,553 shares as direct ownership, rather than indirect ownership.

Footnote F2

Shares reflect the mandatory conversion at an adjusted Conversion Price of $2.25 of the Company's Series A Convertible Prefered Stock ("Series A Preferred") issued in connection with the April 2025 Private Placement. The Reporting Person was originally issued 96,525 shares of Series A Preferred that were converted into 222,222 shares of Common Stock and 1,930 shares that were issued for payment of accrued dividends. Shares were issued upon receipt of stockholder approval, which approval was obtained on June 17, 2026, thereby triggering the automatic conversion of the Series A Preferred into common stock.

Footnote F3

The stock options will vest on the earlier of (i) the day before the next Annual Meeting or (ii) the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Footnote F4

The Series A Convertible Preferred Stock is perpetual and therefore has no expiration date.